Effect of interleukin-1β gene functional polymorphism on dorsolateral prefrontal cortex activity in schizophrenic patients

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 8, 2007, Pages 1090-1093

  Papiol, Sergi ^a   Molina, Vicente ^b   Rosa, Araceli ^a,c   Sanz, Javier ^d   Palomo, Tomás ^d   Fañanás, Lourdes ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Dorsolateral prefrontal cortex; Hypofrontality; Interleukin 1; PET; Schizophrenia

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; ARTICLE; BRAIN CELL; CHROMOSOME 2Q; CLINICAL ARTICLE; COGNITION; DENDRITE; DNA POLYMORPHISM; FEMALE; GENE; GENE FUNCTION; GENE MAPPING; GENETIC VARIABILITY; HUMAN; IL 1B GENE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; ALLELE; BRAIN MAPPING; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METABOLISM; PATHOLOGY;

ADULT; ALLELES; BRAIN MAPPING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; MAGNETIC RESONANCE IMAGING; MALE; POLYMORPHISM, GENETIC; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 36749089452     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30542     Document Type: Article

References (31)

1. Agartz I, Sedvall GC, Terenius L, Kulle B, Frigessi A, Hall H, Jonsson EG. 2006. BDNF gene variants and brain morphology in schizophrenia. Am J Med Genet Part B Neuropsychiatr Genet 141(5):513-523.
2. Allan SM, Tyrrell PJ, Rothwell NJ. 2005. Interleukin-1 and neuronal injury. Nat Rev Immunol 5(8):629-640.
3. Andreasen NC, Rajarethinam R, Cizadlo T, Arndt S, Swayze VW 2nd, Flashman LA, O'Leary DS, Ehrhardt JC, Yuh WT. 1996. Automatic atlas-based volume estimation of human brain regions from MR images. J Comput Assist Tomogr 20(1):98-106.
4. Ashburner J, Friston K. 1997. Multimodal image coregistration and partitioning - A unified framework. Neuroimage 6(3):209-217.
5. Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A 3rd, Noll DC, Cohen JD. 2001. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry 58(3):280-288.
6. Carlsson A. 1988. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1(3):179-186.
7. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, Bingle C, Rogus J, Beck JD, Offenbacher S, Cork MJ, et al. 2006. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15(4):519-529.
8. Desco M, Pascau J, Reig S, Gispert JD, Santos A, Benito B, Molina V, Garcia-Barreno P. 2001. Multimodality image quantification using talairach grid. Proc SPIE Med Imaging 4432:1385-1392.
9. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98(12):6917-6922.
10. Frackowiak R, Friston K, Frith C, Dolan R, Mazziotta J. 1997. Human brain function. San Diego: Academic Press.
11. Fuster JM. 1999. Synopsis of function and dysfunction of the frontal lobe. Acta Psychiatr Scand Suppl 395:51-57.
12. Gilmore JH, Jarskog LF, Vadlamudi S, Lauder J. 2004. Prenatal infection and risk for schizophrenia: IL-I beta, IL-6, and TNF alpha inhibit cortical neuron dendrite development. Neuropsychopharmacology 29(7):1221-1229.
13. Glahn DC, Ragland JD, Abramoff A, Barrett J, Laird AR, Bearden CE, Velligan DI. 2005. Beyond hypofrontality: A quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp 25(1):60-69.
14. Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH. 2006. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 63(7):731-740.
15. Katila H, Hanninen K, Hurme M. 1999. Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry 4(2):179-181.
16. Ling ZD, Potter ED, Lipton JW, Carvey PM. 1998. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp Neurol 149(2):411-423.
17. Meisenzahl EM, Rujescu D, Kirner A, Giegling I, Kathmann N, Leinsinger G, Maag K, Hegerl U, Hahn K, Moller HJ. 2001. Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. Am J Psychiatry 158(8):1316-1319.
18. Molina V, Reig S, Sarramea F, Sanz J, Francisco Artaloytia J, Luque R, Aragues M, Pascau J, Benito C, Palomo T, et al. 2003. Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia. Psychiatry Res 124(3):153-161.
19. Molina V, Sanz J, Reig S, Martinez R, Sarramea F, Luque R, Benito C, Gispert JD, Pascau J, Desco M. 2005. Hypofrontality in men with first-episode psychosis. Br J Psychiatry 186:203-208.
20. Nawa H, Takahashi M, Patterson PH. 2000. Cytokine and growth factor involvement in schizophrenia - Support for the developmental model. Mol Psychiatry 5(6):594-603.
21. Ohnishi T, Hashimoto R, Mori T, Nemoto K, Moriguchi Y, Iida H, Noguchi H, Nakabayashi T, Hori H, Ohmori M, et al. 2006. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 129(Pt 2):399-410.
22. Papiol S, Rosa A, Gutierrez B, Martin B, Salgado P, Catalan R, Arias B, Fananas L. 2004. Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder. J Med Genet 41(3):219-223.
23. Papiol S, Molina V, Desco M, Rosa A, Reig S, Gispert JD, Sanz J, Palomo T, Fananas L. 2005. Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene. Neuroimage 27(4):1002-1006.
24. Potter ED, Ling ZD, Carvey PM. 1999. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res 296(2):235-246.
25. Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL. 2005. Angiotensin II and interleukin-1 interact to increase generation of dopaminergic neurons from neurospheres of mesencephalic precursors. Brain Res Dev Brain Res 158(1-2):120-122.
26. Rosa A, Peralta V, Papiol S, Cuesta MJ, Serrano F, Martinez-Larrea A, Fananas L. 2004a. Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 124(1):10-14.
27. Rosa A, Peralta V, Cuesta MJ, Zarzuela A, Serrano F, Martinez-Larrea A, Fananas L. 2004b. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry 161(6):1110-1112.
28. Snitz BE, MacDonald A III, Cohen JD, Cho RY, Becker T, Carter CS. 2005. Lateral and medial hypofrontality in first-episode schizophrenia: Functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry 162(12):2322-2329.
29. Talairach J, Tournoux P. 1988. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical.
30. Weinberger DR, Berman KF, Illowsky BP. 1988. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 45(7):609-615.
31. Woods RP, Mazziotta JC, Cherry SR. 1993. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17(4):536-546.